上海健麾信息技术股份有限公司 投资者关系管理制度 二○二五年十月 | 求 | | --- | | 第一章 | 总 则 | 1 | | --- | --- | --- | | 第二章 | 投资者关系管理的原则与目的 1 | | | 第三章 | 投资者关系管理的内容 2 | | | 第四章 | 投资者关系管理负责人及其职责 6 | | | 第五章 | 投资者关系管理职能部门及其职责 7 | | | 第六章 | 现场接待细则 | 8 | | 第七章 | 附 则 | 9 | 上海健麾信息技术股份有限公司 投资者关系管理制度 第一章 总 则 第二章 投资者关系管理的原则与目的 1 第一条 为进一步加强上海健麾信息技术股份有限公司（以下简称"公司"） 与投资者及潜在投资者（以下合称"投资者"）之间的信息沟通，增 进投资者对公司的了解和认同，切实保护投资者特别是广大社会公众 投资者的合法权益，促进公司与投资者之间建立长期、稳定的良性关 系，完善公司治理结构，实现公司诚信自律、规范运作，提升公司的 内在价值，根据《中华人民共和国公司法》、《中华人民共和国证券 法》、《上市公司投资者关系管理工作指引》、《上海证券交易所股 票上 ...

Core Insights - The company reported a third-quarter revenue of 112 million, representing a year-on-year growth of 124.93% [1] - The net profit for the third quarter was 3.43 million, showing a year-on-year increase of 36.68% [1] - For the first three quarters, the total revenue reached 270 million, which is a year-on-year increase of 38.55% [1] - However, the net profit for the first three quarters was 8.45 million, reflecting a year-on-year decline of 73.63% [1] Financial Performance - Third-quarter revenue: 112 million, up 124.93% year-on-year [1] - Third-quarter net profit: 3.43 million, up 36.68% year-on-year [1] - Year-to-date revenue (first three quarters): 270 million, up 38.55% year-on-year [1] - Year-to-date net profit (first three quarters): 8.45 million, down 73.63% year-on-year [1]

证券代码：605186 证券简称：健麾信息 公告编号：2025-030 上海健麾信息技术股份有限公司 关于归还临时补充流动资金的募集资金的公告 截至本公告披露日，公司实际使用闲置募集资金临时补充流动资金9,000.00 万元，已将上述募集资金全部归还至募集资金专用账户，并将募集资金的归还情 况告知了保荐机构及保荐代表人，不存在超期情形。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 本次归还募集资金金额（万元） | 9,000.00 | | --- | --- | | 尚未归还的募集资金金额（万元） | 0.00 | | 是否已归还完毕 | √是 □否 | | 归还完毕的具体时间 | 2025年10月20日 | 截至 2025 年 10 月 20 日，公司已累计归还临时补充流动资金的闲置 募集资金人民币_9,000.00_万元。 一、募集资金临时补充流动资金情况 上海健麾信息技术股份有限公司（以下简称"公司" ）于2024年10月29日 召开的第三届董事会第四次会议、第三届监事会第四次会议分别审议通过了《 ...

Market Overview - The medical consumables supply chain SPD sector increased by 0.41% compared to the previous trading day, with Jianfa Zhixin leading the gains [1] - The Shanghai Composite Index closed at 3863.89, up 0.63%, while the Shenzhen Component Index closed at 12813.21, up 0.98% [1] Stock Performance - Jianfa Zhixin (301584) closed at 29.30, up 4.46% with a trading volume of 186,400 shares and a transaction value of 534 million [1] - Dajia Weikang (301126) closed at 11.75, up 3.07% with a trading volume of 53,500 shares and a transaction value of 62.22 million [1] - Jianmo Information (605186) closed at 19.55, up 2.68% with a trading volume of 17,200 shares and a transaction value of 33.43 million [1] - Other notable performers include Hefei China (603122) up 1.91%, Langma Information (300288) up 1.48%, and Seli Medical (603716) up 1.48% [1] Capital Flow - The SPD sector experienced a net outflow of 43.97 million from institutional investors, while retail investors saw a net inflow of 16.33 million [2] - The sector's overall capital flow indicates a mixed sentiment, with institutional investors pulling back while retail investors are more active [2] Individual Stock Capital Flow - Seli Medical (603716) had a net inflow of 12.83 million from institutional investors, but a net outflow of 12.61 million from speculative funds [3] - Dajia Weikang (301126) saw a net inflow of 5.24 million from speculative funds, but a net outflow of 5.91 million from retail investors [3] - Huadong Pharmaceutical (000963) had a net inflow of 2.37 million from speculative funds, while retail investors experienced a net outflow of 4.64 million [3]

Group 1 - The core viewpoint indicates a decline in gold stocks, with Hunan Gold dropping over 4%, Laopu Gold falling over 3%, and Shandong Gold and Chifeng Gold decreasing over 2% [1] - Related ETFs for gold stocks have also seen a decline, with an overall drop of more than 2% [1] Group 2 - Specific ETF performance includes: - Gold Stock ETF (code: 159321) at 1.377, down 0.040 or -2.82% - Gold Stock ETF Fund (code: 159315) at 1.470, down 0.038 or -2.52% - Gold Stock ETF (code: 517520) at 1.797, down 0.046 or -2.50% - Gold Stock ETF (code: 159562) at 1.962, down 0.046 or -2.29% - Gold Stock ETF (code: 517400) at 1.421, down 0.033 or -2.27% - Gold Stock ETF Fund (code: 159322) at 1.461, down 0.033 or -2.21% [2] Group 3 - Analysts suggest that expectations of a Federal Reserve interest rate cut have opened up "valuation space" for gold prices, while geopolitical and economic policy uncertainties have increased gold's "safe-haven value" [2] - Active capital inflows are providing the "fuel" for price increases, with these three factors interwoven to form a solid foundation for the current gold bull market [2]

登录新浪财经APP 搜索【信披】查看更多考评等级 会议召开时间：2025年10月09日 （星期四） 09:00-10:00 会议召开地点：上海证券交易所上证路演中心（网址：https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于2025年09月24日 （星期三） 至09月30日 （星期二）16:00前登录上证路演中心网站首页点 击"提问预征集"栏目或通过公司邮箱stock@g-healthy.com进行提问。公司将在说明会上对投资者普遍关 注的问题进行回答。 上海健麾信息技术股份有限公司（以下简称"公司"）已于2025年8月27日发布公司2025年半年度报告， 为便于广大投资者更全面深入地了解公司2025年半年度经营成果、财务状况，公司计划于2025年10月09 日 （星期四） 09:00-10:00举行2025年半年度业绩说明会，就投资者关心的问题进行交流。 一、 说明会类型 证券代码：605186 证券简称：健麾信息 公告编号：2025-029 上海健麾信息技术股份有限公司 关于召开2025年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不 ...

Group 1 - The company, Jianhui Information (605186), announced that it will hold a 2025 semi-annual performance briefing on October 9, 2025 [1]

证券代码：605186 证券简称：健麾信息 公告编号：2025-029 上海健麾信息技术股份有限公司 关于召开 2025 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025 年 10 月 09 日 （星期四） 09:00-10:00 会议召开地点：上海证券交易所上证路演中心（网址： 本次投资者说明会以网络互动形式召开，公司将针对 2025 年半 年度的经营成果及财务指标的具体情况与投资者进行互动交流和沟 通，在信息披露允许的范围内就投资者普遍关注的问题进行回答。 二、 说明会召开的时间、地点 （一）会议召开时间：2025年10月09日（星期四）09:00-10:00 （二） 会议召开地点：上证路演中心 （三） 会议召开方式：上证路演中心网络互动 https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2025 年 09 月 24 日 （星期三） 至 09 月 30 日 （星 期二）16:00 前登录上证路演中心网 ...

Core Viewpoint - The financial performance of Jianhui Information (605186) for the first half of 2025 shows a mixed picture, with revenue growth but a significant decline in net profit, raising concerns about the company's financial health and operational efficiency [1][2]. Financial Performance Summary - Total revenue for the first half of 2025 reached 159 million yuan, an increase of 9.03% year-on-year [1]. - Net profit attributable to shareholders was 5.03 million yuan, a decrease of 82.99% compared to the previous year [1]. - The gross profit margin fell to 44.72%, down 26.18% year-on-year, indicating reduced profitability [1]. - The net profit margin dropped to 1.28%, a decline of 93.44% year-on-year [1]. - Total expenses (selling, administrative, and financial) amounted to 40.75 million yuan, accounting for 25.68% of revenue, an increase of 5.86% year-on-year [1]. Cash Flow and Receivables - The company reported a significant increase in operating cash flow, with a net cash flow from operating activities improving by 80.58% year-on-year [6]. - Accounts receivable represented 1478.08% of net profit, indicating a high level of outstanding payments [1][6]. Cost Structure and Expenses - Operating costs increased by 52.89%, attributed to higher sales and a greater proportion of new products [2]. - Management expenses rose by 14.46%, primarily due to increased depreciation from the conversion of logistics projects into fixed assets [4]. - Financial expenses surged by 100.93%, driven by an increase in short-term borrowings [6]. Business Model and Market Position - The company is focusing on expanding into new business areas such as intelligent logistics and mobile robotics, which have shown some success [2]. - Historical data indicates a median Return on Invested Capital (ROIC) of 16.34%, but the recent performance shows a decline, with a ROIC of only 2.8% last year [6]. - The company’s reliance on research and marketing for performance necessitates a thorough examination of these drivers [6].

Overview - The company announced a provision for asset impairment for the first half of 2025, amounting to a total credit impairment loss of 16,045,044.10 yuan [2][4]. Provision for Asset Impairment - The provision is made in accordance with the "Enterprise Accounting Standards" and the company's accounting policies to reflect the financial status and operating results accurately [2]. - The company assesses the credit risk of financial instruments by comparing the risk of default at the balance sheet date with that at initial recognition, determining if there has been a significant increase in credit risk [3]. Financial Impact - The provision for impairment will reduce the company's total profit by 16.045 million yuan for the current period [4]. - This provision is consistent with the "Enterprise Accounting Standards" and is based on the company's actual situation, ensuring a true and accurate reflection of the asset status without affecting the company's operations significantly [4]. Additional Notes - The financial data related to the impairment provision has not been audited by an accounting firm and will be confirmed by the annual audit [4].